The Discounted Cash Flow (DCF) valuation of LogicBio Therapeutics Inc (LOGC) is (1,323.42) USD. With the latest stock price at 7.73 USD, the upside of LogicBio Therapeutics Inc based on DCF is -17220.6%.
Based on the latest price of 7.73 USD and our DCF valuation, LogicBio Therapeutics Inc (LOGC) is a sell. selling LOGC stocks now will result in a potential gain of 17220.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.0% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3,267.02) - (843.73) | (1,323.42) |
| Upside | -42364.2% - -11015.0% | -17220.6% |